Treatment Updates in RCC

Insights from 2023 ASCO® Annual Meeting
C

ASCO® 2023 Insights: "HR-QoL Measures in RCC - Patient-Reported Relevance of Items of the FKSI-19, EORTC QLQ-C30, and EQ-5D"

By Insights from 2023 ASCO® Annual Meeting FEATURING Cristiane Decat Bergerot
By Insights from 2023 ASCO® Annual Meeting FEATURING Cristiane Decat Bergerot
31 views
July 1, 2023
Comments 0
Login to view comments. Click here to Login
08:35

Patient-Reported Outcomes of Patients With Advanced RCC Treated With…

Northwestern Medicine Oncology and Hematology

D. Cella

260 views
10:22

Clinical Implications of CheckMate 9ER Data: Applications for Practi…

Rush University Medical Center

A. Tan

466 views
08:15

ASCO GU 2023 3-Year Follow-Up From The Phase 3 CheckMate 9ER Trial: …

ASCO GU 2023 Conference Coverage

M. Burotto

369 views
22:44

ASCO® 2023 Summary: "RCC Updates From The Recent Trials"

Dana-Farber Cancer Institute

W. Xu, T. Choueiri

240 views
17:48

ASCO® 2023 Insights: "Combination Therapies Come of Age in Kidney Ca…

Insights from 2023 ASCO® Annual Meeting

D. Braun

50 views
09:59

ASCO® 2023 Insights: "When to Play the Systemic Therapy Card in Olig…

Insights from 2023 ASCO® Annual Meeting

K. Runcie

145 views
23:16

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients With…

Insights from 2023 ASCO® Annual Meeting

B. McGregor

454 views
07:12

ASCO® 2023 Insights: "Association of Host Immune Signatures With Res…

Insights from 2023 ASCO® Annual Meeting

E. Saad

89 views
17:19

Optimal Toxicity Management in mRCC

Kate Young

141 views
20:18

Dana-Farber Cancer Institute Kidney Cancer Updates From ASCO GU 2023

Dana-Farber Cancer Institute

W. Xu, T. Choueiri

260 views
10:24

Front-Line Treatment of Renal Cell Carcinoma

Benjamin Garmezy

424 views
15:44

How to Select Frontline Therapy for Metastatic Clear Cell RCC

Matthew Campbell

577 views
09:12

ASCO GU 2023 Longitudinal Detection of ctDNA in Patients With Advanc…

ASCO GU 2023 Conference Coverage

A. Basu, C. Park

249 views